PULM
Price:
$6.12
Market Cap:
$22.35M
Pulmatrix, Inc., a clinical stage biotechnology company, discovers and develops inhaled therapies to prevent and treat respiratory and other diseases with unmet medical needs in the United States. The company focuses on developing products based on its inhaled small particles easily respirable and emitted (iSPERSE) technology, which enables delivery of small or large molecule drugs to the lungs by inhalation for local or systemic applications. It engages in developing Pulmazole, an inhaled anti-fungal drug for the treatment of allergic bronchopulmonary aspergillosis in patients with asthma, and in patients with cystic fibrosis; PUR1800, a narrow spectrum kinase inhibitor that is in Phase 1b ...[Read more]
Industry
Biotechnology
IPO Date
2014-03-21
Stock Exchange
NASDAQ
Ticker
PULM
According to Pulmatrix, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 11.57M. This represents a change of -418.29% compared to the average of -3635101.37 of the last 4 quarters.
The mean historical Enterprise Value of Pulmatrix, Inc. over the last ten years is 4.07M. The current 11.57M Enterprise Value has changed 28.32% with respect to the historical average. Over the past ten years (40 quarters), PULM's Enterprise Value was at its highest in in the September 2015 quarter at 56.65M. The Enterprise Value was at its lowest in in the September 2022 quarter at -26984979.51.
Average
4.07M
Median
5.82M
Minimum
-27825031.92
Maximum
31.14M
Discovering the peaks and valleys of Pulmatrix, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 160.42%
Maximum Annual Enterprise Value = 31.14M
Minimum Annual Increase = -746.73%
Minimum Annual Enterprise Value = -27825031.92
Year | Enterprise Value | Change |
---|---|---|
2023 | -3624445.54 | -83.06% |
2022 | -21393920.12 | -23.11% |
2021 | -27825031.92 | -746.73% |
2020 | 4.30M | -151.38% |
2019 | -8373846.00 | -214.08% |
2018 | 7.34M | -72.80% |
2017 | 26.98M | 160.42% |
2016 | 10.36M | -52.46% |
2015 | 21.80M | -30.00% |
2015 | 31.14M | -25.80% |
The current Enterprise Value of Pulmatrix, Inc. (PULM) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-17614465.86
5-year avg
-11382958.56
10-year avg
4.07M
Pulmatrix, Inc.’s Enterprise Value is less than Capricor Therapeutics, Inc. (2.43B), less than Akari Therapeutics, Plc (17.47M), greater than Diffusion Pharmaceuticals Inc. (-1447403.00), less than Soleno Therapeutics, Inc. (2.45B), less than Onconova Therapeutics, Inc. (0), greater than Catalyst Biosciences, Inc. (4.51M), less than Bio-Path Holdings, Inc. (19.42M), greater than Moleculin Biotech, Inc. (3.00M), greater than Bellerophon Therapeutics, Inc. (-819813.00), greater than Crinetics Pharmaceuticals, Inc. (-3709207.00), less than Assembly Biosciences, Inc. (4.93B), less than Neoleukin Therapeutics, Inc. (68.59M), greater than Instil Bio, Inc. (-6333315.00), less than CytomX Therapeutics, Inc. (165.40M), less than Achilles Therapeutics plc (39.67M), greater than null (-38865958.00),
Company | Enterprise Value | Market cap |
---|---|---|
2.43B | $846.65M | |
17.47M | $18.72M | |
-1447403.00 | $8.98M | |
2.45B | $2.49B | |
0 | $20.90M | |
4.51M | $19.42M | |
19.42M | $3.53M | |
3.00M | $8.20M | |
-819813.00 | $672.79K | |
-3709207.00 | $5.20B | |
4.93B | $95.60M | |
68.59M | $8.20M | |
-6333315.00 | $170.65M | |
165.40M | $69.65M | |
39.67M | $43.57M | |
-38865958.00 | $0 |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Pulmatrix, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Pulmatrix, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is Pulmatrix, Inc.'s Enterprise Value?
What is the highest Enterprise Value for Pulmatrix, Inc. (PULM)?
What is the 3-year average Enterprise Value for Pulmatrix, Inc. (PULM)?
What is the 5-year average Enterprise Value for Pulmatrix, Inc. (PULM)?
How does the current Enterprise Value for Pulmatrix, Inc. (PULM) compare to its historical average?